N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide

C115H113Cl2N25O10 — CID 157124315

IUPACN-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide
SMILESCNC(=O)c1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.CNC(=O)c1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1
InChIInChI=1S/C31H27N7O4.C30H38N8O2.2C27H24ClN5O2/c1-32-29(39)19-12-22(14-23(13-19)42-3)37(10-11-38-30(40)24-6-4-5-7-25(24)31(38)41)21-8-9-26-27(15-21)35-28(17-33-26)20-16-34-36(2)18-20;1-31-30(39)21-14-25(16-26(15-21)40-5)38(13-12-37-10-8-23(9-11-37)35(2)3)24-6-7-27-28(17-24)34-29(19-32-27)22-18-33-36(4)20-22;1-32-17-19(14-30-32)27-15-29-25-8-7-21(12-26(25)31-27)33(16-18-5-4-6-20(28)9-18)22-10-23(34-2)13-24(11-22)35-3;1-32-16-19(14-30-32)27-15-29-25-9-8-20(12-26(25)31-27)33(17-18-6-4-5-7-24(18)28)21-10-22(34-2)13-23(11-21)35-3/h4-9,12-18H,10-11H2,1-3H3,(H,32,39);6-7,14-20,23H,8-13H2,1-5H3,(H,31,39);4-15,17H,16H2,1-3H3;4-16H,17H2,1-3H3
InChIKeyAIIKAKOOZMVDFG-UHFFFAOYSA-N
MW2076.24 g/mol
LogP19.47
Rot. Bonds31

About N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide

N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide (PubChem CID 157124315) has the molecular formula C115H113Cl2N25O10 and a molecular weight of 2076.24 g/mol. Its IUPAC name is N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide.

Molecular Properties

Compound NameN-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide
PubChem CID157124315
Molecular FormulaC115H113Cl2N25O10
Molecular Weight2076.24 g/mol
Exact Mass2073.85
IUPAC NameN-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide
SMILESCNC(=O)c1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.CNC(=O)c1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1
InChIInChI=1S/C31H27N7O4.C30H38N8O2.2C27H24ClN5O2/c1-32-29(39)19-12-22(14-23(13-19)42-3)37(10-11-38-30(40)24-6-4-5-7-25(24)31(38)41)21-8-9-26-27(15-21)35-28(17-33-26)20-16-34-36(2)18-20;1-31-30(39)21-14-25(16-26(15-21)40-5)38(13-12-37-10-8-23(9-11-37)35(2)3)24-6-7-27-28(17-24)34-29(19-32-27)22-18-33-36(4)20-22;1-32-17-19(14-30-32)27-15-29-25-8-7-21(12-26(25)31-27)33(16-18-5-4-6-20(28)9-18)22-10-23(34-2)13-24(11-22)35-3;1-32-16-19(14-30-32)27-15-29-25-9-8-20(12-26(25)31-27)33(17-18-6-4-5-7-24(18)28)21-10-22(34-2)13-23(11-21)35-3/h4-9,12-18H,10-11H2,1-3H3,(H,32,39);6-7,14-20,23H,8-13H2,1-5H3,(H,31,39);4-15,17H,16H2,1-3H3;4-16H,17H2,1-3H3
InChIKeyAIIKAKOOZMVDFG-UHFFFAOYSA-N
XLogP19.47
TPSA344.80 Ų
H-Bond Donors2
H-Bond Acceptors32
Rotatable Bonds31
Heavy Atoms152
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002076.24
LogP ≤ 519.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide?
The IUPAC name of N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide (CID 157124315) is N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide.
What is the SMILES notation for N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide?
The canonical SMILES for N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide is CNC(=O)c1cc(OC)cc(N(CCN2C(=O)c3ccccc3C2=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.CNC(=O)c1cc(OC)cc(N(CCN2CCC(N(C)C)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2cccc(Cl)c2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(Cc2ccccc2Cl)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.
What is the InChIKey of N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide?
The InChIKey is AIIKAKOOZMVDFG-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H27N7O4.C30H38N8O2.2C27H24ClN5O2/c1-32-29(39)19-12-22(14-23(13-19)42-3)37(10-11-38-30(40)24-6-4-5-7-25(24)31(38)41)21-8-9-26-27(15-21)35-28(17-33-26)20-16-34-36(2)18-20;1-31-30(39)21-14-25(16-26(15-21)40-5)38(13-12-37-10-8-23(9-11-37)35(2)3)24-6-7-27-28(17-24)34-29(19-32-27)22-18-33-36(4)20-22;1-32-17-19(14-30-32)27-15-29-25-8-7-21(12-26(25)31-27)33(16-18-5-4-6-20(28)9-18)22-10-23(34-2)13-24(11-22)35-3;1-32-16-19(14-30-32)27-15-29-25-9-8-20(12-26(25)31-27)33(17-18-6-4-5-7-24(18)28)21-10-22(34-2)13-23(11-21)35-3/h4-9,12-18H,10-11H2,1-3H3,(H,32,39);6-7,14-20,23H,8-13H2,1-5H3,(H,31,39);4-15,17H,16H2,1-3H3;4-16H,17H2,1-3H3.
What are the key properties of N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide?
N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide has a molecular weight of 2076.24 g/mol, XLogP of 19.47, 31 rotatable bonds, 2 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-[(3-chlorophenyl)methyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;3-[2-[4-(dimethylamino)piperidin-1-yl]ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide;3-[2-(1,3-dioxoisoindol-2-yl)ethyl-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]amino]-5-methoxy-N-methylbenzamide is sourced from PubChem (CID 157124315), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).